Yoshiomi Nakazuru

Statistics

Publications

Citations

H-Index

Active since

2014

Affiliations

Yoshiomi Nakazuru is an author at Pfizer (Japan) specializing in pharmacology, glucagon-like peptide 1 receptor agonism, and pelvic inflammatory disease therapy.

Publications per year

2014–2022

Publications

A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of danuglipron ( <scp>PF</scp> ‐06882961), an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, in Japanese adults with type 2 diabetes mellitus

Ryosuke Ono, Kenichi Furihata, Yoshihiko Ichikawa et al. · Diabetes Obesity and Metabolism · 2022 · 33 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Efficacy and safety of metronidazole injection for the treatment of infectious peritonitis, abdominal abscess and pelvic inflammatory diseases in Japan

Hiroshige Mikamo, Miyako Matsumizu, Yoshiomi Nakazuru et al. · Journal of Infection and Chemotherapy · 2014 · 13 citations

Medicine, Infectious Diseases, Pharmacology +9

1–2 of 2